Sharon Hesterlee, PhD, is the chief research officer for the Muscular Dystrophy Association (MDA).
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.